Jenison, MI, United States of America

Tung V Le


Average Co-Inventor Count = 3.3

ph-index = 7

Forward Citations = 398(Granted Patents)


Company Filing History:


Years Active: 1992-1998

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations of Tung V Le

Introduction

Tung V Le is a notable inventor based in Jenison, MI (US), recognized for his contributions to the field of chemistry and pharmaceuticals. He holds a total of 8 patents, showcasing his innovative approaches to complex chemical processes.

Latest Patents

One of his latest patents is titled "Process for R (+) - An improved process for the preparation of R(+)1,2,3,6-tetrahydro-4-phenyl-1-(3-phenyl-3-cyclohexen-1-yl)methyl!pyridine." This patent describes a novel synthesis where 5-oxo-3-phenyl-3-cyclohexene-carboxylic acid is converted in five operations to the desired product. Additionally, it includes processes for the resolution of 5-oxo-3-phenyl-3-cyclohexenecarboxylic acid using cinchonidine and α-chymotrypsin to afford valuable intermediates. Another significant patent is "Process for trans-6[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one," which outlines an improved process for preparing trans-6-[2-(substituted-pyrrole-1-yl)alkyl]pyran-2-ones through a seven-step synthesis.

Career Highlights

Tung V Le is currently associated with Warner-Lambert Company, where he applies his expertise in developing innovative pharmaceutical solutions. His work has significantly impacted the field, particularly in the synthesis of compounds that serve as intermediates in drug development.

Collaborations

Throughout his career, Tung has collaborated with esteemed colleagues such as Donald E Butler and Thomas N Nanninga. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Tung V Le's contributions to the field of chemistry and pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His innovative processes continue to advance the development of valuable pharmaceutical compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…